Search Results 691-700 of 16178 for SC

  1. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection - Mayo Clinic

    J Scott; Gordon SC. Stuart C; Muir AJ. Andrew J; Aguilar H. Humberto; Agarwal K. Kosh; Dore GJ. Gregory J; Lin CW. Chih-Wei; Liu R. Ran; Lovell SS. Sandra S ...

  2. Publications - Sabrina D. Phillips, M.D. - Mayo Clinic

    ... SC, Darakjian AA, Jain A, Whelan ER, Kotha A, Gorelov DJ, Phillips SD, Fairweather D. Cardiac defects of hypermobile Ehlers-Danlos syndrome and ...

  3. CA 125 test - Mayo Clinic

    Learn how doctors use this blood test to measure levels of a tumor marker associated with ovarian cancer, fallopian tube cancer and other types of cancer.

  4. Publications - Tamra I. Ranasinghe, M.B.B.S. - Mayo Clinic

    ... SC, Mantovani GP, Kim YD, Krishnaiah B, Elangovan C, Lingam S, Qureshi AY, Fridman S, Alvarado A, Khasiyev F, Linares G, Mannino M, Terruso V, Tountopoulou ...

  5. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  6. Publications - Mike M. Harper, Jr., M.D. - Mayo Clinic

    2004 Mar; 29(3):339-51. View PubMed; Tsujino A, Maertens C, Ohno K, Shen XM, Fukuda T, Harper CM, Cannon SC, Engel AG. Myasthenic syndrome caused by mutation ...

  7. https://www.mayoclinic.org/arabic_procedure_concepts.xml

  8. Publications - Shannon P. Sheedy, M.D. - Mayo Clinic

    ... SC, Petkovska I, Zheng J, Sosa RE, Gangai N, Zhao B, Schwartz LH, Horvat N, Gollub MJ. Can MRI radiomics distinguish residual adenocarcinoma from acellular ...

  9. Publications - Michael Rivera, M.D. - Mayo Clinic

    ... SC. Outcomes and Patterns of Recurrence for Anaplastic Thyroid Cancer Treated With Comprehensive Chemoradiotherapy. Pract Radiat Oncol. 2022 Mar-Apr; 12 (2): ...

  10. Recurrent Cancer Clinical Trials - Mayo Clinic Research

    The primary purpose of this study is to assess the efficacy (overall response rate) of subcutaneous (SC) via on body delivery system (SC-OBDS) isatuximab in ...